CD98 heavy chain as a prognostic biomarker and target for cancer treatment

P **a, A Dubrovska - Frontiers in Oncology, 2023 - frontiersin.org
The SLC3A2 gene encodes for a cell-surface transmembrane protein CD98hc (4F2).
CD98hc serves as a chaperone for LAT1 (SLC7A5), LAT2 (SLC7A8), y+ LAT1 (SLC7A7), y+ …

The structure, function and regulation of protein tyrosine phosphatase receptor type J and its role in diseases

H Li, P Zhang, C Liu, Y Wang, Y Deng, W Dong, Y Yu - Cells, 2022 - mdpi.com
Protein tyrosine phosphatase receptor type J (PTPRJ), also known as DEP-1, HPTPη, or
CD148, belongs to the R3 subfamily of receptor protein tyrosine phosphatases (RPTPs). It …

N-glycosylation is crucial for trafficking and stability of SLC3A2 (CD98)

L Console, M Scalise, S Salerno, R Scanga… - Scientific reports, 2022 - nature.com
The type II glycoprotein CD98 (SLC3A2) is a membrane protein with pleiotropic roles in
cells, ranging from modulation of inflammatory processes, host–pathogen interactions to …

A network pharmacology approach to uncover the molecular mechanisms of herbal formula ban‐**a‐**e‐**n‐Tang

M Yang, J Chen, L Xu, X Shi, X Zhou… - Evidence‐Based …, 2018 - Wiley Online Library
Ban‐**a‐**e‐**n‐Tang (BXXXT) is a classical formula from Shang‐Han‐Lun which is one of
the earliest books of TCM clinical practice. In this work, we investigated the therapeutic …

Heteromeric solute carriers: function, structure, pathology and pharmacology

SJ Fairweather, N Shah, S Brӧer - Protein Reviews: Volume 21, 2021 - Springer
Solute carriers form one of three major superfamilies of membrane transporters in humans,
and include uniporters, exchangers and symporters. Following several decades of …

Ferroptosis and its emerging role in esophageal cancer

R Maimaitizunong, K Wang, H Li - Frontiers in Molecular Biosciences, 2022 - frontiersin.org
The occurrence and development of tumors involve a series of life activities of cells, among
which cell death has always been a crucial part in the research of tumor mechanisms and …

Anti‐tumor effects of mAb against l‐type amino acid transporter 1 (LAT1) bound to human and monkey LAT1 with dual avidity modes

S Ueda, H Hayashi, T Miyamoto, S Abe, K Hirai… - Cancer …, 2019 - Wiley Online Library
l‐Type amino acid transporter 1 (LAT 1) disulfide linked to CD 98 heavy chain (hc) is highly
expressed in most cancer cells, but weakly expressed in normal cells. In the present study …

Oncogenic transformation of NIH/3T3 cells by the overexpression of L-type amino acid transporter 1, a promising anti-cancer target

N Hayashi, A Yamasaki, S Ueda, S Okazaki… - …, 2021 - pmc.ncbi.nlm.nih.gov
L-type amino acid transporter 1 (LAT1)/SLC7A5 is the first identified CD98 light chain
disulfide linked to the CD98 heavy chain (CD98hc/SLC3A2). LAT1 transports large neutral …

Presence and transmission of mitochondrial heteroplasmic mutations in human populations of European and African ancestry

C Liu, JL Fetterman, Y Qian, X Sun, TW Blackwell… - Mitochondrion, 2021 - Elsevier
We investigated the concordance of mitochondrial DNA heteroplasmic mutations
(heteroplasmies) in 6745 maternal pairs of European (EA, n= 4718 pairs) and African (AA …

PTPRJ is a negative regulator of insulin signaling in neuronal cells, impacting protein biosynthesis, and neurite outgrowth

J Ulke, S Chopra, OLJ Kadiri, P Geserick… - Journal of …, 2024 - Wiley Online Library
Central insulin resistance has been linked to the development of neurodegenerative
diseases and mood disorders. Various proteins belonging to the enzyme family of protein …